PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,938,004 | -20.1% | 1,922,662 | +10.3% | 0.00% | -100.0% |
| Q2 2023 | $24,950,265 | +196.8% | 1,742,337 | +48.0% | 0.00% | – |
| Q1 2023 | $8,407,329 | -30.4% | 1,177,497 | +9.4% | 0.00% | – |
| Q4 2022 | $12,079,508 | +12.4% | 1,076,605 | +11.0% | 0.00% | – |
| Q3 2022 | $10,745,000 | -32.5% | 969,754 | -48.6% | 0.00% | – |
| Q2 2022 | $15,909,000 | -39.8% | 1,884,852 | -3.0% | 0.00% | -100.0% |
| Q1 2022 | $26,441,000 | -30.3% | 1,942,701 | +0.8% | 0.00% | 0.0% |
| Q4 2021 | $37,921,000 | -34.9% | 1,927,844 | +6.3% | 0.00% | 0.0% |
| Q3 2021 | $58,218,000 | +10.3% | 1,813,651 | +16.3% | 0.00% | 0.0% |
| Q2 2021 | $52,783,000 | -5.0% | 1,559,289 | +5.4% | 0.00% | -50.0% |
| Q1 2021 | $55,573,000 | +16.1% | 1,479,592 | +2.7% | 0.00% | +100.0% |
| Q4 2020 | $47,868,000 | +75.8% | 1,440,937 | +94.1% | 0.00% | 0.0% |
| Q3 2020 | $27,222,000 | +18.3% | 742,349 | +6.2% | 0.00% | 0.0% |
| Q2 2020 | $23,008,000 | +333.6% | 699,119 | +240.2% | 0.00% | – |
| Q1 2020 | $5,306,000 | -17.3% | 205,512 | -0.2% | 0.00% | – |
| Q4 2019 | $6,415,000 | – | 205,995 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 5,827,415 | $187,060,000 | 14.97% |
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $66,378,000 | 14.44% |
| Abingworth LLP | 1,203,135 | $38,512,000 | 8.74% |
| Penn Mutual Asset Management, LLC | 86,940 | $2,791,000 | 4.41% |
| GREAT POINT PARTNERS LLC | 220,863 | $7,090,000 | 1.65% |
| RA Capital Management | 3,115,008 | $99,992,000 | 1.39% |
| StepStone Group LP | 422,085 | $13,549,000 | 0.88% |
| Summit Rock Advisors, LP | 34,100 | $1,094,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 186,210 | $5,977,000 | 0.42% |
| Eventide Asset Management | 600,000 | $19,260,000 | 0.25% |